|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 13.598,00 GBX | +0,62% |
|
-2,82% | +29,73% |
| 06:47 | Zweedse aandelen in Noord-Amerika - Ericsson daalt met 1,0 procent | FW |
| 04/12 | Salesforce Agentforce Life Sciences door AstraZeneca gekozen als wereldwijd platform voor klantbetrokkenheid | CI |
Voorlopige winst- en verliesrekening: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 26.617 | 37.417 | 44.351 | 45.811 | 54.073 | 58.538 | 62.277 | 66.172 |
| Variatie | - | 40,58% | 18,53% | 3,29% | 18,03% | 8,26% | 6,39% | 6,25% |
| EBITDA 1 | 8.311 | 7.586 | 9.237 | 13.580 | 16.691 | 19.742 | 22.245 | 24.580 |
| Variatie | - | -8,72% | 21,76% | 47,02% | 22,91% | 18,28% | 12,68% | 10,49% |
| Bedrijfsresultaat (EBIT) 1 | 7.340 | 9.928 | 13.350 | 14.534 | 16.928 | 18.737 | 21.040 | 23.491 |
| Variatie | - | 35,26% | 34,47% | 8,87% | 16,47% | 10,69% | 12,29% | 11,65% |
| Betaalde rente 1 | -782 | -862 | -1.251 | -1.282 | -1.284 | -1.262 | -1.124 | -963,9 |
| Resultaat voor belastingen (EBT) 1 | 3.916 | -265 | 2.501 | 6.899 | 8.691 | 13.019 | 15.347 | 17.760 |
| Variatie | - | -106,77% | 1.043,77% | 175,85% | 25,97% | 49,79% | 17,89% | 15,72% |
| Nettowinst (verlies) 1 | 3.196 | 112 | 3.288 | 5.961 | 7.035 | 10.303 | 12.066 | 13.682 |
| Variatie | - | -96,5% | 2.835,71% | 81,3% | 18,02% | 46,45% | 17,11% | 13,39% |
| Datum van publicatie | 11/02/21 | 10/02/22 | 9/02/23 | 8/02/24 | 6/02/25 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Balansprognose: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | 11.867 | 24.383 | 22.923 | 22.510 | 24.570 | 21.483 | 15.305 | 9.162 |
| Variatie | - | 105,47% | -5,99% | -1,8% | 9,15% | -12,56% | -28,76% | -40,14% |
| Datum van publicatie | 11/02/21 | 10/02/22 | 9/02/23 | 8/02/24 | 6/02/25 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Verwachte kasstroom: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 961 | 1.091 | 1.091 | 1.361 | 1.924 | 2.515 | 2.644 | 2.538 |
| Variatie | - | 13,53% | 0% | 24,75% | 41,37% | 30,71% | 5,13% | -4,01% |
| Vrije kasstroom (FCF) 1 | 3.838 | 4.872 | 8.717 | 8.984 | 9.937 | 8.959 | 12.305 | 14.381 |
| Variatie | - | 26,94% | 78,92% | 3,06% | 10,61% | -9,84% | 37,36% | 16,87% |
| Datum van publicatie | 11/02/21 | 10/02/22 | 9/02/23 | 8/02/24 | 6/02/25 | - | - | - |
1USD in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: AstraZeneca PLC
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 31,22% | 20,27% | 20,83% | 29,64% | 30,87% | 33,72% | 35,72% | 37,15% |
| EBIT-marge (%) | 27,58% | 26,53% | 30,1% | 31,73% | 31,31% | 32,01% | 33,78% | 35,5% |
| EBT-marge (%) | 14,71% | -0,71% | 5,64% | 15,06% | 16,07% | 22,24% | 24,64% | 26,84% |
| Nettomarge (%) | 12,01% | 0,3% | 7,41% | 13,01% | 13,01% | 17,6% | 19,37% | 20,68% |
| FCF-marge (%) | 14,42% | 13,02% | 19,65% | 19,61% | 18,38% | 15,3% | 19,76% | 21,73% |
| Vrije kasstroom/nettoresultaat (%) | 120,09% | 4.350% | 265,12% | 150,71% | 141,25% | 86,96% | 101,98% | 105,11% |
Winstgevendheid | ||||||||
| ROA | 4,99% | 8,77% | 3,26% | 11,48% | 12,51% | 9,65% | 12,15% | 12,87% |
| ROE | 36,72% | 27,51% | 27,23% | 29,77% | 32,11% | 32,57% | 32,26% | 31,48% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | 1,43x | 3,21x | 2,48x | 1,66x | 1,47x | 1,09x | 0,69x | 0,37x |
| Schuld/vrije kasstroom | 3,09x | 5x | 2,63x | 2,51x | 2,47x | 2,4x | 1,24x | 0,64x |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 3,61% | 2,92% | 2,46% | 2,97% | 3,56% | 4,3% | 4,25% | 3,84% |
| CAPEX / EBITDA (%) | 11,56% | 14,38% | 11,81% | 10,02% | 11,53% | 12,74% | 11,89% | 10,33% |
| CAPEX / FCF (%) | 25,04% | 22,39% | 12,52% | 15,15% | 19,36% | 28,07% | 21,49% | 17,65% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 3,655 | 4,179 | 6,287 | 6,623 | 7,589 | 10,68 | 11,72 | 13,54 |
| Variatie | - | 14,33% | 50,46% | 5,34% | 14,58% | 40,71% | 9,79% | 15,47% |
| Dividend per aandeel 1 | 2,8 | 2,87 | 2,9 | 2,9 | 3,1 | 3,225 | 3,399 | 3,565 |
| Variatie | - | 2,5% | 1,05% | 0% | 6,9% | 4,03% | 5,4% | 4,87% |
| Nettoactief per aandeel 1 | 11,91 | 27,69 | 23,93 | 25,06 | 26,09 | 29,4 | 33,71 | 39,44 |
| Variatie | - | 132,51% | -13,6% | 4,74% | 4,13% | 12,67% | 14,64% | 17,02% |
| WPA 1 | 2,44 | 0,08 | 2,11 | 3,81 | 4,5 | 6,636 | 7,706 | 8,86 |
| Variatie | - | -96,72% | 2.537,5% | 80,57% | 18,11% | 47,48% | 16,12% | 14,97% |
| Aantal aandelen (in duizend) | 1.312.660 | 1.549.159 | 1.549.528 | 1.549.926 | 1.550.317 | 1.550.713 | 1.550.713 | 1.550.713 |
| Datum van publicatie | 11/02/21 | 10/02/22 | 9/02/23 | 8/02/24 | 6/02/25 | - | - | - |
1USD
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | 27,2x | 23,4x |
| PBR-ratio | 6,14x | 5,35x |
| EV/omzet | 5,15x | 4,74x |
| Dividendrendement | 1,79% | 1,88% |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Trader
Trader
Beleggings
Beleggings
Globaal
Globaal
Kwaliteit van de publicaties
Kwaliteit van de publicaties
ESG MSCI
A
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
22
Laatste slotkoers
180,44USD
Gemiddelde koersdoel
197,15USD
Spread / Gemiddelde doel
+9,26%
Kwartaalomzet - Afwijkingspercentage
Kies jouw editie
Alle financiële informatie op nationaal niveau
